Catalyst Wire Dossier Catalyst Wire Dossier

p53MVA vaccine

p53MVA vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for p53MVA vaccine, covering 2018-04-30 to 2018-04-30. Get the full timeline:

Most recent: Clinical Trial Update: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 1]

See pricing